- The United States Biomedical Advanced Research and Development Authority (BARDA) has announced Vaxxas will receive US$2 million (AU$3.2 million) as a Concept Stage Winner in its multi-stage $50 ...

(CNN) — US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms through the Biomedical Advanced Research and Development Authority, ...

The Trump administration on Tuesday eliminated 22 mRNA vaccine development projects for COVID-19 and bird flu, a stark shift away from technology credited with bringing the United States out of the ...

The Department of Health and Human Services (HHS) is winding down its mRNA vaccine development activities under the Biomedical Advanced Research and Development Authority (BARDA), the agency announced ...

This decision appears to have bypassed the standard review processes typically managed by career scientists at the NIH and Biomedical Advanced Research and Development Authority. HealthDay News — The ...

The Biomedical Advanced Research and Development Authority canceled its annual biomedical event for industry. The meeting focuses on biomedical countermeasures and pandemic responses. (Endpoints News) ...

WASHINGTON — The chairman of the Senate Health, Education, Labor and Pensions Committee denounced a decision by the federal government to phase out mRNA vaccine development, warning that could hurt ...

Orexo AB’s subsidiary Orexo US Inc. has been awarded $8 million in funding by the U.S. Biomedical Advanced Research and Development Authority (BARDA) to support the development of OX-390, an ...

CHO Plus was awarded a project agreement from the Biomedical Advanced Research and Development Authority’s (BARDA) Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium) for up to ...